Berdagang Vir Biotechnology VIR

VirBiotechnology carta live

Asas Instrumen

Weekly Search
Weekly
Daily
Tarikh Tutup Perubahan Perubahan (%): Buka Tinggi Rendah

VirBiotechnology news

Emma Rose 2025 Jul 03, 08:35

US Economy on Stagflation Watch: Apollo Global Management's Outlook

Ava Grace 2025 Jul 03, 08:35

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Sophia Claire 2025 Jul 03, 07:35

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Sophia Claire 2025 Jul 03, 07:35

AI Podcast: Stock Market Melt-Up Potential? Examining the Bull Run

Noah Lee 2025 Jul 03, 07:35

AI Podcast: Does the Gold-Platinum Ratio Signal Stock Market Risk?

Berita Terkini

Tunjukkan lebih lagi
US Debt Ceiling in Focus
Ava Grace 2025 Oct 25, 00:00

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Emma Rose 2025 Oct 25, 00:00

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

Noah Lee 2025 Oct 25, 00:00

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Emma Rose 2025 Oct 25, 00:00

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Sophia Claire 2025 Oct 25, 00:00

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

Emma Rose 2025 Oct 25, 00:00

US Government Shutdown Threatens October Inflation Data Release

Sophia Claire 2025 Oct 24, 00:00

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

Emma Rose 2025 Oct 24, 00:00

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk

Maklumat

Sebaran nilai

0.06

Spread (%)

1.0204 %

Leveraj

1:10

Faedah semalaman (Beli)

-0.0597 %

Faedah semalaman (Jual)

-0.0292 %

Mata wang

USD

Waktu perdagangan

Pasaran dibuka

Jumaat

13:31 - 19:59

Isnin

14:31-20:59

Selasa

14:31-20:59

Rabu

14:31-20:59

Khamis

14:31-20:59

Analisis dan statistik

Buka

---

Tutup Terdahulu

---

Tinggi/Rendah 52 Minggu

--- – ---

Modal pasaran

820996096

Saham Tertunggak

138916426

Tarikh Pendapatan (Seterusnya)

0000-00-00

Hasil Div

Tarikh Selepas Dividen

Kadar dividen tahunan depan

0

Hasil dividen tahunan depan

0

EPS

-4.01

Ketahui lebih lanjut mengenai instrumen ini

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

latest_education_articles

Tunjukkan lebih lagi
Ghko B 2025 Oct 26, 16:00

What is non-farm payroll (NFP): Is higher NFP good or bad?

Stocks Forex
Ghko B 2025 Oct 26, 16:00

What is crude oil trading: how to start crude oil investing with markets.com

Commodities
Ghko B 2025 Oct 26, 16:00

Crypto trading basics: What is PooCoin, should you buy PooCoin Token 2026?

Crypto CFD Trading
Trustpilot